Sibrotuzumab is a humanized monoclonal antibody intended for the treatment of cancer.

Pascolizumab is a humanized monoclonal antibody for the treatment of asthma.

Food and Drug Administration approval of daclizumab, the first humanized antibody therapeutic.

Demcizumab is a humanized monoclonal antibody designed for the treatment of cancer.

It is possible to produce a humanized antibody without creating a chimeric intermediate.

Ponezumab is a humanized monoclonal antibody designed for the treatment of Alzheimer's disease.

Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors.

Therefore, the drug is a humanized monoclonal antibody used against a tumor.

Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.

Romosozumab is a humanized monoclonal antibody designed for the treatment of osteoporosis.